Sansum Diabetes Research Institute
Dedicated to improving the lives of people impacted by diabetes through research, education, and care.
Sansum Diabetes Research Institute (SDRI) has been on the cutting edge of diabetes research, education, and clinical care since our founding in 1944 by Dr. William Sansum, the first U.S. physician to manufacture and administer insulin in the treatment of diabetes. Dr. Sansum also developed and disseminated a novel and effective dietary approach for managing type 1 diabetes.
For over 76 years SDRI’s priority has remained committed to improving the lives of those impacted by diabetes.
Today SDRI has an international reputation for research and innovation in the field of type 1 diabetes including the artificial pancreas system and diabetes in pregnancy. SDRI has broadened its area of expertise to address a range of issues in type 2 diabetes in an effort to impact this growing epidemic.
SDRI’s intention is to continue our partnerships with top global institutions including Harvard University and the Mayo Clinic to understand how to improve the use of artificial pancreas technology in high-risk groups that live with type 1 diabetes including woman who are pregnant, seniors, children, and adolescents. In addition, SDRI will continue examine artificial pancreas technology during exercise and research how various nutrition therapies improve the effectiveness of artificial pancreas technology.